New drug tested for Tough-to-Treat blood cancer
Disease control
Recruiting now
This early-stage trial is testing a new drug called tegavivint in patients with an aggressive type of lymphoma that has returned or stopped responding to other treatments. The main goals are to find a safe dose and understand the drug's side effects. Researchers hope the drug can…
Phase: PHASE1 • Sponsor: Lapo Alinari • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC